SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041725
Filing Date
2019-11-07
Accepted
2019-11-07 16:06:47
Documents
73
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q svra-10q_20190930.htm 10-Q 2473749
2 EX-31.1 svra-ex311_6.htm EX-31.1 14787
3 EX-31.2 svra-ex312_9.htm EX-31.2 14539
4 EX-32.1 svra-ex321_7.htm EX-32.1 10704
  Complete submission text file 0001564590-19-041725.txt   8501426

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT svra-20190930.xml EX-101.INS 1822299
6 XBRL TAXONOMY EXTENSION SCHEMA svra-20190930.xsd EX-101.SCH 70841
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svra-20190930_cal.xml EX-101.CAL 55712
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svra-20190930_def.xml EX-101.DEF 194907
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20190930_lab.xml EX-101.LAB 499588
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20190930_pre.xml EX-101.PRE 366307
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 191200322
SIC: 2834 Pharmaceutical Preparations